SRPT
Sarepta Therapeutics Inc
18.70$
+1.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -87.2% | +332.6% | +2,751.6% | +94.7% | +26.5% | +41.8% | +30.0% | +32.9% | +33.3% | +53.0% | +15.6% | |
| – | +55.4% | -99.9% | +5,556.2% | +365.0% | +65.5% | +12.0% | +53.1% | +44.2% | +7.4% | +112.2% | +176.2% | |
| – | – | +322.3% | +2,682.7% | +81.2% | +21.5% | +47.0% | +26.9% | +31.1% | +37.8% | +44.8% | -16.8% | |
| – | +55.4% | +28.6% | -11.5% | +141.0% | +39.6% | +28.8% | +6.8% | +13.7% | +0.0% | -8.3% | +89.2% | |
| – | +52.2% | +8.2% | +47.6% | +75.2% | +35.6% | +11.6% | -11.1% | +59.7% | +6.7% | +15.8% | -14.1% | |
| – | +54.3% | +22.8% | +6.8% | +110.2% | +68.7% | +1.1% | +2.3% | +24.9% | +2.4% | +0.3% | +44.7% | |
| – | – | – | – | – | – | – | – | – | – | – | -401.6% | |
| – | – | -60.8% | +980.6% | +483.1% | -9.0% | +95.5% | +6.0% | -16.2% | -58.7% | -16.4% | -47.1% | |
| – | – | – | – | – | – | – | – | – | – | – | -369.3% | |
| – | – | – | – | -133.6% | – | -11.0% | -115.8% | – | +17.4% | +60.8% | -56.2% | |
| – | – | – | – | – | – | – | – | – | – | – | -403.3% | |
| – | – | – | – | – | – | – | – | – | – | – | -304.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.